Literature DB >> 22441639

Cutaneous manifestations of Hyper IgE syndrome.

Yoshiyuki Minegishi1, Masako Saito.   

Abstract

Hyper-IgE syndrome (HIES) is a primary immunodeficiency disorder characterized by atopic manifestations and susceptibility to infections with extracellular bacteria and fungi. Atopic manifestations include atopic dermatitis-like skin lesion and extremely high serum IgE levels. Most of the extracellular bacterial infections are caused by Staphylococcus aureus, which is associated with milder inflammation compared to normal. Recent studies have revealed that the most cases of the HIES are caused by dominant negative mutations in STAT3 gene. Cutaneous manifestations of HIES includes newborn rash, eczematoid dermatitis, cold abscesses, mucocutaneous candidiasis, and coarse texture of the facial skin. Impaired Th17 cell development due to the defective IL-6 signaling in T cells and impaired induced regulatory T (iTreg) cell generation due to defective IL-10 signaling in dendritic cells may, at least in part, account for the cutaneous pathology of HIES.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441639     DOI: 10.2332/allergolint.12-RAI-0423

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  10 in total

1.  Eczematous dermatitis due to subcutaneous teriparatide injection.

Authors:  Howard Chu; Dae Suk Kim
Journal:  Endocrine       Date:  2015-11-28       Impact factor: 3.633

2.  Investigation of Skin Barrier Functions and Allergic Sensitization in Patients with Hyper-IgE Syndrome.

Authors:  Gábor Mócsai; Krisztián Gáspár; Zsolt Dajnoki; Beáta Tóth; Edit Gyimesi; Tamás Bíró; László Maródi; Andrea Szegedi
Journal:  J Clin Immunol       Date:  2015-10-09       Impact factor: 8.317

Review 3.  Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.

Authors:  Jing Wu; Li Hong; Tong-Xin Chen
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-15       Impact factor: 4.919

Review 4.  Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications.

Authors:  Elaine C Siegfried; Adelaide A Hebert
Journal:  J Clin Med       Date:  2015-05-06       Impact factor: 4.241

Review 5.  Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.

Authors:  Hassan Hashemi; Masoumeh Mohebbi; Shiva Mehravaran; Mehdi Mazloumi; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

6.  Pediatric hyperimmunoglobulin E syndrome: A case series of 4 children in China.

Authors:  Huifeng Fan; Li Huang; Diyuan Yang; Yunting Lin; Gen Lu; Yaping Xie; Jialu Yu; Dongwei Zhang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

7.  Skin manifestations in pediatric patients with primary immunodeficiency diseases (PIDs) in a tertiary care hospital in Colombia.

Authors:  William López-Quintero; Daniela Cleves; Jose David Gomez-Vasco; Paola Pérez; Jaime Patiño; Diego Medina-Valencia; Harry Pachajoa; Laura Torres-Canchala; Andres Vidal; Manuela Olaya
Journal:  World Allergy Organ J       Date:  2021-03-01       Impact factor: 4.084

8.  Essential Role of STAT3 Signaling in Hair Follicle Homeostasis.

Authors:  Kosuke Miyauchi; Sewon Ki; Masao Ukai; Yoshie Suzuki; Kentaro Inoue; Wataru Suda; Takeshi Matsui; Yoshihiro Ito; Kenya Honda; Haruhiko Koseki; Osamu Ohara; Reiko J Tanaka; Mariko Okada-Hatakeyama; Masato Kubo
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 9.  Inborn errors of immunity and related microbiome.

Authors:  Raja Hazime; Fatima-Ezzohra Eddehbi; Saad El Mojadili; Nadia Lakhouaja; Ikram Souli; Abdelmouïne Salami; Bouchra M'Raouni; Imane Brahim; Mohamed Oujidi; Morad Guennouni; Ahmed Aziz Bousfiha; Brahim Admou
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

10.  IL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytes.

Authors:  Maren Simanski; Franziska Rademacher; Lena Schröder; Hanna Maria Schumacher; Regine Gläser; Jürgen Harder
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.